Haleon PLC closed 6.63% below its 52-week high of £4.01, which the company reached on September 18th.

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and ...

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond's North Side at a cost of $54 million, the company announced Monday. Based in England ...

Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares in GSK lost 8% of their value today in the wake of the analyst comments, while Sanofi fell 3% and Haleon was down 6%, collectively wiping tens of billions of dollars off their valuations.

Glenn Youngkin dubbing the region a “pharma corridor” during Monday’s announcement of major investments and opportunities at Haleon, an international drug manufacturing company. The United ...